“CRISPR-CAS9 GENE EDITING THERAPEUTICS: FROM FIRST APPROVAL TO EXPANDING CLINICAL PIPELINE”. 2026. Global Conference on Medical and Health Sciences 1 (9): 29-36. http://econferencia.com/index.php/5/article/view/1409.